. "The aim of this retrospective study was to evaluate FDG-PET findings in the lungs of patients with Hodgkin lymphoma.16 of the 22 patients included in the study had a negative PET finding after the first course of chemotherapy, i.e. they were considered to be in a complete remission of the disease. PET and HRCT revealed postradiation pneumonitis in two patients. In two patients a progression appeared after the first course of chemotherapy, in accordance with PET findings the progression was outside the lungs. In other two patients a persistence of lung involvement was observed on PET after the initial chemotherapy. These patients are without any relaps. One of them underwent lung biopsy which confirmed postchemotherapeutic changes. Positive FDG-PET findings in the lung parenchyma are quite frequent after the initial chemotherapy in patients with Hodgkin lymphoma with initial involvement of the lungs (4/22), the majority is represented by benign postchemotherapeutic and postradiation changes" . "Hodgkin lymphoma; chemotherapy; PET; FDG"@en . . "RIV/00023884:_____/06:00000002" . "C\u00EDlem t\u00E9to retrospektivn\u00ED studie bylo zhodnocen\u00ED plicn\u00EDch n\u00E1lez\u016F u pacient\u016F s Hodgkinsk\u00FDm lymfomem se vstupn\u00EDm posti\u017Een\u00EDm plicn\u00EDho parenchymu, kte\u0159\u00ED podstoupili PET vy\u0161et\u0159en\u00ED po \u00FAvodn\u00ED l\u00E9\u010Db\u011B a v pr\u016Fb\u011Bhu dal\u0161\u00EDho sledov\u00E1n\u00ED. 16 z 22 pacient\u016F s HL se vstupn\u00EDm posti\u017Een\u00EDm plic bylo po inici\u00E1ln\u00ED l\u00E9\u010Db\u011B s negativn\u00EDm plicn\u00EDm n\u00E1lezem na PET v kompletn\u00ED remisi. PET a HRCT odhalila postradia\u010Dn\u00ED pneumonitidu u dvou pacient\u016F. U dvou dal\u0161\u00EDch pacient\u016F do\u0161lo po inici\u00E1ln\u00ED chemoterapii k progresi onemocn\u011Bn\u00ED, ale dle PET n\u00E1lezu ne v oblasti plic. U jin\u00FDch dvou pacient\u016F perzistoval plicn\u00ED n\u00E1lez na PET po inici\u00E1ln\u00ED chemoterapii. Tito pacienti jsou d\u00E1le bez zn\u00E1mek relapsu. Jeden z nich podstoupil biopsii plic, kter\u00E1 potvrdila postchemoterapeutick\u00E9 zm\u011Bny. P\u0159esto\u017Ee jsou PET pozitivn\u00ED n\u00E1lezy v plicn\u00EDm parenchymu u pacient\u016F s HL po \u00FAvodn\u00ED l\u00E9\u010Db\u011B dosti \u010Dast\u00E9 (4/22), v\u011Bt\u0161ina t\u011Bchto n\u00E1lez\u016F reprezentuje postchemoterapeutick\u00E9 a postradia\u010Dn\u00ED zm\u011Bny."@cs . . . "DE - Spolkov\u00E1 republika N\u011Bmecko" . . "491902" . "2006" . "PET finfings in the lungs of patients treated for Hodgkin disease" . "P(NR8033)" . "1"^^ . "1619-7070" . "3"^^ . . "[CD4CE3B78E77]" . . . . "Vyhodnocen\u00ED PET n\u00E1lez\u016F na plic\u00EDch u pacient\u016F l\u00E9\u010Den\u00FDch pro Hodgkinsk\u00FD lymfom"@cs . "1"^^ . "European Journal of Nuclear Medicine and Molecular Imaging" . . "PET finfings in the lungs of patients treated for Hodgkin disease"@en . . . "PET finfings in the lungs of patients treated for Hodgkin disease"@en . . . "RIV/00023884:_____/06:00000002!RIV07-MZ0-00023884" . "33" . . "PET finfings in the lungs of patients treated for Hodgkin disease" . . "S-256-256" . "The aim of this retrospective study was to evaluate FDG-PET findings in the lungs of patients with Hodgkin lymphoma.16 of the 22 patients included in the study had a negative PET finding after the first course of chemotherapy, i.e. they were considered to be in a complete remission of the disease. PET and HRCT revealed postradiation pneumonitis in two patients. In two patients a progression appeared after the first course of chemotherapy, in accordance with PET findings the progression was outside the lungs. In other two patients a persistence of lung involvement was observed on PET after the initial chemotherapy. These patients are without any relaps. One of them underwent lung biopsy which confirmed postchemotherapeutic changes. Positive FDG-PET findings in the lung parenchyma are quite frequent after the initial chemotherapy in patients with Hodgkin lymphoma with initial involvement of the lungs (4/22), the majority is represented by benign postchemotherapeutic and postradiation changes"@en . "Vyhodnocen\u00ED PET n\u00E1lez\u016F na plic\u00EDch u pacient\u016F l\u00E9\u010Den\u00FDch pro Hodgkinsk\u00FD lymfom"@cs . "Skopalov\u00E1, M." .